US Patent 7985411 Activatable recombinant neurotoxins
Patent 7985411 was granted and assigned to Allergan, Inc. on July, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+240 characters)
Article
Patent abstract
Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
J. Oliver Dolly0
Kuo Chion Chan0
Yan Li0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07985411 Activatable recombinant neurotoxins US Patent 7985411 Activatable recombinant neurotoxins
Infobox
Patent Number
079854110
Patent Number
79854110
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079854110
Date of Patent
July 26, 2011
0Patent Application Number
121935270
Date Filed
August 18, 2008
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07985411 Activatable recombinant neurotoxins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07985411
Date of patent
July 26, 2011
Patent application number
12193527
Date Filed
August 18, 2008
Patent primary examiner
Find more entities like US Patent 7985411 Activatable recombinant neurotoxins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
